MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors

Cancer immunotherapy critically depends on fitness of cytotoxic and helper T cell responses. Dysfunctional cytotoxic T cell states in the tumor microenvironment (TME) are a major cause of resistance to immunotherapy. Intratumoral myeloid cells, particularly blood-borne myeloids (bbm), are key driver...

Full description

Saved in:
Bibliographic Details
Main Authors: Kilian, Michael (Author) , Sheinin, Ron (Author) , Tan, Chin Leng (Author) , Friedrich, Mirco (Author) , Krämer, Christopher (Author) , Kaminitz, Ayelet (Author) , Sanghvi, Khwab (Author) , Lindner, Katharina (Author) , Chih, Yu-Chan (Author) , Cichon, Frederik (Author) , Richter, Benjamin (Author) , Jung, Stefanie (Author) , Jähne, Kristine (Author) , Ratliff, Miriam (Author) , Prins, Robert M. (Author) , Etminan, Nima (Author) , Deimling, Andreas von (Author) , Wick, Wolfgang (Author) , Madi, Asaf (Author) , Bunse, Lukas (Author) , Platten, Michael (Author)
Format: Article (Journal)
Language:English
Published: 13 January 2023
In: Cancer cell
Year: 2023, Volume: 41, Issue: 2, Pages: 235-251
ISSN:1878-3686
DOI:10.1016/j.ccell.2022.12.007
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ccell.2022.12.007
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1535610822005931
Get full text
Author Notes:Michael Kilian, Ron Sheinin, Chin Leng Tan, Mirco Friedrich, Christopher Krämer, Ayelet Kaminitz, Khwab Sanghvi, Katharina Lindner, Yu-Chan Chih, Frederik Cichon, Benjamin Richter, Stefanie Jung, Kristine Jähne, Miriam Ratliff, Robert M. Prins, Nima Etminan, Andreas von Deimling, Wolfgang Wick, Asaf Madi, Lukas Bunse, and Michael Platten

MARC

LEADER 00000caa a2200000 c 4500
001 1832484084
003 DE-627
005 20250109092130.0
007 cr uuu---uuuuu
008 230126s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ccell.2022.12.007  |2 doi 
035 |a (DE-627)1832484084 
035 |a (DE-599)KXP1832484084 
035 |a (OCoLC)1389533349 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kilian, Michael  |d 1990-  |e VerfasserIn  |0 (DE-588)1220319422  |0 (DE-627)1736693255  |4 aut 
245 1 0 |a MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors  |c Michael Kilian, Ron Sheinin, Chin Leng Tan, Mirco Friedrich, Christopher Krämer, Ayelet Kaminitz, Khwab Sanghvi, Katharina Lindner, Yu-Chan Chih, Frederik Cichon, Benjamin Richter, Stefanie Jung, Kristine Jähne, Miriam Ratliff, Robert M. Prins, Nima Etminan, Andreas von Deimling, Wolfgang Wick, Asaf Madi, Lukas Bunse, and Michael Platten 
264 1 |c 13 January 2023 
300 |a 27 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar 12 January 2023, Version des Artikels 13 February 2023 
500 |a Gesehen am 26.01.2023 
520 |a Cancer immunotherapy critically depends on fitness of cytotoxic and helper T cell responses. Dysfunctional cytotoxic T cell states in the tumor microenvironment (TME) are a major cause of resistance to immunotherapy. Intratumoral myeloid cells, particularly blood-borne myeloids (bbm), are key drivers of T cell dysfunction in the TME. We show here that major histocompatibility complex class II (MHCII)-restricted antigen presentation on bbm is essential to control the growth of brain tumors. Loss of MHCII on bbm drives dysfunctional intratumoral tumor-reactive CD8+ T cell states through increased chromatin accessibility and expression of Tox, a critical regulator of T cell exhaustion. Mechanistically, MHCII-dependent activation of CD4+ T cells restricts myeloid-derived osteopontin that triggers a chronic activation of NFAT2 in tumor-reactive CD8+ T cells. In summary, we provide evidence that MHCII-restricted antigen presentation on bbm is a key mechanism to directly maintain functional cytotoxic T cell states in brain tumors. 
650 4 |a CD8 T cell dysfunction 
650 4 |a glioblastoma 
650 4 |a glioma 
650 4 |a macrophages 
650 4 |a MHC class II 
650 4 |a microenvironment 
650 4 |a myeloid cells 
650 4 |a NFAT 
650 4 |a osteopontin 
650 4 |a TOX 
700 1 |a Sheinin, Ron  |e VerfasserIn  |4 aut 
700 1 |a Tan, Chin Leng  |e VerfasserIn  |0 (DE-588)125452441X  |0 (DE-627)1797000837  |4 aut 
700 1 |a Friedrich, Mirco  |e VerfasserIn  |0 (DE-588)1126663794  |0 (DE-627)881255246  |0 (DE-576)484646923  |4 aut 
700 1 |a Krämer, Christopher  |d 1997-  |e VerfasserIn  |0 (DE-588)1279191635  |0 (DE-627)1832479978  |4 aut 
700 1 |a Kaminitz, Ayelet  |e VerfasserIn  |4 aut 
700 1 |a Sanghvi, Khwab  |d 1990-  |e VerfasserIn  |0 (DE-588)1201828864  |0 (DE-627)1685962580  |4 aut 
700 1 |a Lindner, Katharina  |d 1994-  |e VerfasserIn  |0 (DE-588)1308397348  |0 (DE-627)1869026217  |4 aut 
700 1 |a Chih, Yu-Chan  |d 1997-  |e VerfasserIn  |0 (DE-588)1317602609  |0 (DE-627)1879494531  |4 aut 
700 1 |a Cichon, Frederik  |d 1983-  |e VerfasserIn  |0 (DE-588)1220319589  |0 (DE-627)1736693700  |4 aut 
700 1 |a Richter, Benjamin  |e VerfasserIn  |0 (DE-588)1279194502  |0 (DE-627)1832482286  |4 aut 
700 1 |a Jung, Stefanie  |e VerfasserIn  |4 aut 
700 1 |a Jähne, Kristine  |e VerfasserIn  |4 aut 
700 1 |a Ratliff, Miriam  |d 1979-  |e VerfasserIn  |0 (DE-588)1012081028  |0 (DE-627)660894602  |0 (DE-576)344899357  |4 aut 
700 1 |a Prins, Robert M.  |e VerfasserIn  |4 aut 
700 1 |a Etminan, Nima  |d 1978-  |e VerfasserIn  |0 (DE-588)134245202  |0 (DE-627)56561374X  |0 (DE-576)300399871  |4 aut 
700 1 |a Deimling, Andreas von  |d 1959-  |e VerfasserIn  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 aut 
700 1 |a Wick, Wolfgang  |d 1970-  |e VerfasserIn  |0 (DE-588)120297736  |0 (DE-627)080586929  |0 (DE-576)186221320  |4 aut 
700 1 |a Madi, Asaf  |e VerfasserIn  |4 aut 
700 1 |a Bunse, Lukas  |d 1988-  |e VerfasserIn  |0 (DE-588)1051941229  |0 (DE-627)787187399  |0 (DE-576)407600426  |4 aut 
700 1 |a Platten, Michael  |d 1971-  |e VerfasserIn  |0 (DE-588)121627780  |0 (DE-627)081431848  |0 (DE-576)261969811  |4 aut 
773 0 8 |i Enthalten in  |t Cancer cell  |d Cambridge, Mass. : Cell Press, 2002  |g 41(2023), 2, Seite 235-251  |h Online-Ressource  |w (DE-627)343970082  |w (DE-600)2074034-7  |w (DE-576)097935972  |x 1878-3686  |7 nnas  |a MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors 
773 1 8 |g volume:41  |g year:2023  |g number:2  |g pages:235-251  |g extent:27  |a MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors 
856 4 0 |u https://doi.org/10.1016/j.ccell.2022.12.007  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1535610822005931  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230126 
994 |a 2023 
998 |g 121627780  |a Platten, Michael  |m 121627780:Platten, Michael  |d 60000  |d 62700  |e 60000PP121627780  |e 62700PP121627780  |k 0/60000/  |k 1/60000/62700/  |p 21  |y j 
998 |g 1051941229  |a Bunse, Lukas  |m 1051941229:Bunse, Lukas  |d 60000  |d 62700  |e 60000PB1051941229  |e 62700PB1051941229  |k 0/60000/  |k 1/60000/62700/  |p 20 
998 |g 120297736  |a Wick, Wolfgang  |m 120297736:Wick, Wolfgang  |d 60000  |d 62700  |e 60000PW120297736  |e 62700PW120297736  |k 0/60000/  |k 1/60000/62700/  |p 18 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 60000  |d 63400  |e 60000PD103034115X  |e 63400PD103034115X  |k 0/60000/  |k 1/60000/63400/  |p 17 
998 |g 134245202  |a Etminan, Nima  |m 134245202:Etminan, Nima  |d 60000  |d 62600  |e 60000PE134245202  |e 62600PE134245202  |k 0/60000/  |k 1/60000/62600/  |p 16 
998 |g 1012081028  |a Ratliff, Miriam  |m 1012081028:Ratliff, Miriam  |p 14 
998 |g 1279194502  |a Richter, Benjamin  |m 1279194502:Richter, Benjamin  |d 60000  |e 60000PR1279194502  |k 0/60000/  |p 11 
998 |g 1317602609  |a Chih, Yu-Chan  |m 1317602609:Chih, Yu-Chan  |d 140000  |e 140000PC1317602609  |k 0/140000/  |p 9 
998 |g 1308397348  |a Lindner, Katharina  |m 1308397348:Lindner, Katharina  |d 140000  |e 140000PL1308397348  |k 0/140000/  |p 8 
998 |g 1201828864  |a Sanghvi, Khwab  |m 1201828864:Sanghvi, Khwab  |d 60000  |d 62700  |e 60000PS1201828864  |e 62700PS1201828864  |k 0/60000/  |k 1/60000/62700/  |p 7 
998 |g 1279191635  |a Krämer, Christopher  |m 1279191635:Krämer, Christopher  |d 60000  |e 60000PK1279191635  |k 0/60000/  |p 5 
998 |g 1126663794  |a Friedrich, Mirco  |m 1126663794:Friedrich, Mirco  |d 910000  |d 910100  |e 910000PF1126663794  |e 910100PF1126663794  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 125452441X  |a Tan, Chin Leng  |m 125452441X:Tan, Chin Leng  |d 140000  |e 140000PT125452441X  |k 0/140000/  |p 3 
998 |g 1220319422  |a Kilian, Michael  |m 1220319422:Kilian, Michael  |d 60000  |e 60000PK1220319422  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1832484084  |e 4252203910 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Online verfügbar 12 January 2023, Version des Artikels 13 February 2023","Gesehen am 26.01.2023"],"language":["eng"],"person":[{"given":"Michael","family":"Kilian","role":"aut","display":"Kilian, Michael"},{"role":"aut","family":"Sheinin","display":"Sheinin, Ron","given":"Ron"},{"display":"Tan, Chin Leng","family":"Tan","role":"aut","given":"Chin Leng"},{"given":"Mirco","display":"Friedrich, Mirco","role":"aut","family":"Friedrich"},{"given":"Christopher","family":"Krämer","role":"aut","display":"Krämer, Christopher"},{"given":"Ayelet","display":"Kaminitz, Ayelet","family":"Kaminitz","role":"aut"},{"given":"Khwab","display":"Sanghvi, Khwab","family":"Sanghvi","role":"aut"},{"given":"Katharina","role":"aut","family":"Lindner","display":"Lindner, Katharina"},{"role":"aut","family":"Chih","display":"Chih, Yu-Chan","given":"Yu-Chan"},{"given":"Frederik","family":"Cichon","role":"aut","display":"Cichon, Frederik"},{"given":"Benjamin","display":"Richter, Benjamin","role":"aut","family":"Richter"},{"given":"Stefanie","family":"Jung","role":"aut","display":"Jung, Stefanie"},{"display":"Jähne, Kristine","family":"Jähne","role":"aut","given":"Kristine"},{"given":"Miriam","display":"Ratliff, Miriam","family":"Ratliff","role":"aut"},{"given":"Robert M.","display":"Prins, Robert M.","family":"Prins","role":"aut"},{"given":"Nima","role":"aut","family":"Etminan","display":"Etminan, Nima"},{"given":"Andreas von","display":"Deimling, Andreas von","family":"Deimling","role":"aut"},{"display":"Wick, Wolfgang","family":"Wick","role":"aut","given":"Wolfgang"},{"role":"aut","family":"Madi","display":"Madi, Asaf","given":"Asaf"},{"role":"aut","family":"Bunse","display":"Bunse, Lukas","given":"Lukas"},{"family":"Platten","role":"aut","display":"Platten, Michael","given":"Michael"}],"id":{"eki":["1832484084"],"doi":["10.1016/j.ccell.2022.12.007"]},"recId":"1832484084","type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Michael Kilian, Ron Sheinin, Chin Leng Tan, Mirco Friedrich, Christopher Krämer, Ayelet Kaminitz, Khwab Sanghvi, Katharina Lindner, Yu-Chan Chih, Frederik Cichon, Benjamin Richter, Stefanie Jung, Kristine Jähne, Miriam Ratliff, Robert M. Prins, Nima Etminan, Andreas von Deimling, Wolfgang Wick, Asaf Madi, Lukas Bunse, and Michael Platten"]},"origin":[{"dateIssuedDisp":"13 January 2023","dateIssuedKey":"2023"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"eki":["343970082"],"zdb":["2074034-7"],"issn":["1878-3686"]},"recId":"343970082","origin":[{"dateIssuedKey":"2002","publisherPlace":"Cambridge, Mass. ; New York, NY","dateIssuedDisp":"2002-","publisher":"Cell Press ; Elsevier"}],"disp":"MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumorsCancer cell","language":["eng"],"note":["Gesehen am 28.02.11"],"pubHistory":["1.2002 -"],"part":{"volume":"41","text":"41(2023), 2, Seite 235-251","extent":"27","issue":"2","pages":"235-251","year":"2023"},"title":[{"title_sort":"Cancer cell","title":"Cancer cell"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"27 S."}],"title":[{"title":"MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors","title_sort":"MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors"}]} 
SRT |a KILIANMICHMHCCLASSII1320